Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Syncom Resource Report Resource Website 50+ mentions |
Syncom (RRID:SCR_004118) | Syncom | commercial organization | Independent contract research organization / small and medium sized enterprise (CRO/SME) that assists pharma and biotechnology companies with medicinal chemistry programs, providing tailor-made custom synthesis solutions. Primary activities include synthesis of key building blocks, route scouting services, process research activities, scale up, medicinal chemistry services and hit-to-lead optimization. On custom basis they also synthesize metabolites, impurities, reference standards and stable labelled compounds. Their services are backed up by state-of-the-art analytical technologies such as HPLC, GC, LC-MS, GC-MS and NMR. These technologies can be offered as stand-alone analytical services as well. Syncom also has expertise in chiral technology. The firm has designed and synthesized numerous unique scaffolds, yielding many patent applications and clinical candidates. Name changed to Symeres after merger with Mercachem., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | organic chemistry, custom synthesis, medicinal chemistry, chiral, metabolite, impurity, reference standard, compound, contract research organization | is related to: European Lead Factory | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_158595 | SCR_004118 | SciCrunch Registry | Symeres, Syncom: Contract Research in Organic Chemistry, Syncom BV | 2026-09-26 02:13:39 | 81 | |||||||
|
Almirall Resource Report Resource Website 1+ mentions |
Almirall (RRID:SCR_003947) | Almirall | commercial organization | A pharmaceutical company committed to provide valuable medicines through their own R&D efforts, licenses and collaborations. Through seeking innovative medicines they aim to become a relevant player in respiratory and dermatology diseases with also a strong interest in gastroenterology and pain. The company is headquartered in Barcelona, Spain, and has 14 affiliates in Europe and North America and trading capacity in 22 countries. | gastroenterology, respiratory, dermatology, pharmaceutical, medicine, drug | is related to: Open PHACTS | Respiratory disease, Dermatologic disease, Pain, Gastrointestinal disease, Gastrointestinal condition | nlx_158340 | SCR_003947 | SciCrunch Registry | S.A., Laboratories Almirall S.A., Almirall | 2026-09-26 02:13:35 | 4 | |||||||
|
Simulations Plus Resource Report Resource Website 10+ mentions |
Simulations Plus (RRID:SCR_003946) | commercial organization | Commercial developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) and Physiologically-Based Pharmacokinetic (PBPK) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemical, cosmetic, herbicide, and food ingredient industries. Their software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better projects decisions sooner. Consulting services: Their team of highly-skilled scientists is available to assist with your discovery and development activities on a project-by-project basis. They now offer expanded pharmacodynamic modeling services, NONMEM analysis, and regulatory report writing assistance. Their ultimate goal is to develop tools and systems which bridge PBPK modeling with clinical trial data analysis. Training workshops & User Groups: they offer hands-on introductory and advanced training workshops in the United States, Europe, and Asia throughout the year. | pharmaceutical, modelling, simulation, pharmacodynamic, biotechnology, chemical, cosmetic, food ingredient, herbicide, drug development, drug, pharmacokinetic | is related to: ORBITO | License required | nlx_158339, ISNI: 0000 0004 0506 5380, grid.418738.1, Wikidata: Q7521341 | https://ror.org/02p0yhm49 | SCR_003946 | SciCrunch Registry | Simulations Plus Inc. | 2026-09-26 02:13:38 | 37 | |||||||
|
Edelris Resource Report Resource Website 1+ mentions |
Edelris (RRID:SCR_004112) | Edelris | commercial organization | A commercial medicinal chemistry company dedicated to the design and synthesis of natural product-mimetic screening compounds, Hit-to-Lead & Lead Optimization projects and Custom Synthesis. Aiming at the acceleration of the lead discovery and optimization process in pharma and biotech research organizations, EDELRIS uses its validated chemistry and drug discovery expertise to provide novelty to its customers with exclusive or non-exclusive small molecules and with efficient hit-to-lead optimization capabilities. EDELRIS has a wide range of services and based on its experience in various and complementary fields, the team is capable to deliver innovative solutions to synthetic and medicinal chemistry problems faced by clients. | screening compound, chemical, small molecule, drug discovery, natural product | is related to: European Lead Factory | nlx_158590 | SCR_004112 | SciCrunch Registry | 2026-09-26 02:13:40 | 2 | |||||||||
|
Qualissima Resource Report Resource Website |
Qualissima (RRID:SCR_003941) | Qualissima | commercial organization | A Research as a Service (RaaS) Company founded by a Clinical Pharmacologist and Neuropsychiatrist that offers to its partners (health products industries and public research), 3 platforms: * Clinical research (CRO and SMO) * Scientific & regulatory consulting * Online surveys (Web portal) Their Research & Development profile allows them to propose innovative concepts such as : * Patient-Leader studies * Translational research studies (fMRI, innovative biomarkers, modeling, ...) * Behavioral parameters as biomarkers studies Qualissima also proposes proof of concept studies, proof of activities studies, medical devices studies and observational studies. | neurodegeneration, central nervous system, cardiology, dermatology, infectiology, cancerology, biomarker, clinical trial, clinical | is related to: PharmaCog | grid.492092.4, nlx_158328 | https://ror.org/008zpgd78 | SCR_003941 | SciCrunch Registry | Qualissima GmbH | 2026-09-26 02:13:38 | 0 | |||||||
|
Pivot Park Screening Centre Resource Report Resource Website |
Pivot Park Screening Centre (RRID:SCR_004115) | PPSC | commercial organization | Commercial organization dedicated to open innovation, providing automated cellular and biochemical in-vitro screening experiments, and ultra-High Throughput Screening (uHTS) services. The Pivot Park facilities include MSD''s former screening centre which comprise two unique robotic systems for in-vitro screening. Because the new screening centre was able to retain a significant number of the original screening staff, it offers a wealth of experience in assay development, screening and automation in a new, open setting. | high throughput screening, cellular, biochemical, in-vitro, screening, assay, assay development | is related to: European Lead Factory | nlx_158593 | SCR_004115 | SciCrunch Registry | Pivot Park Screening Center | 2026-09-26 02:13:38 | 0 | ||||||||
|
GOlr Resource Report Resource Website 1+ mentions |
GOlr (RRID:SCR_003939) | GOlr | software resource | A public Solr index for the Gene Ontology. This index will replace some of the query functionality for GOOSE as well as become the new backend for AmiGO 2 and other services. | solr |
is used by: AmiGO has parent organization: Gene Ontology |
Public | nlx_158322 | http://golr.berkeleybop.org/ | SCR_003939 | SciCrunch Registry | Gene Ontology Solr index | 2026-09-26 02:13:35 | 4 | ||||||
|
Kyoto University; Kyoto; Japan Resource Report Resource Website |
Kyoto University; Kyoto; Japan (RRID:SCR_004108) | Kyodai | university | National university in Kyoto, Japan. It is the second oldest Japanese university, one of Asia highest ranked universities and one of Japan National Seven Universities. |
is parent organization of: Kyoto Encyclopedia of Genes and Genomes Expression Database is parent organization of: GenomeNet is parent organization of: GLIDA : GPCR-Ligand Database is parent organization of: ODB - Operon database is parent organization of: KEGG is parent organization of: National Bio Resource Project for the Rat. is parent organization of: BSORF - Bacillus Subtilis Genome Database is parent organization of: DINIES is parent organization of: NBRP Medaka Pattern Match is parent organization of: CNACS |
Wikidata:Q336264, grid.258799.8, ISNI:0000 0004 0372 2033, nlx_60798, Crossref funder ID:501100005683 | https://ror.org/02kpeqv85 | SCR_004108 | SciCrunch Registry | 2026-09-26 02:13:38 | 0 | |||||||||
|
American Society of Transplantation Resource Report Resource Website 1+ mentions |
American Society of Transplantation (RRID:SCR_003970) | AST | professional organization | An organization of transplant professionals dedicated to advancing the field of transplantation and improving patient care by promoting research, education, advocacy, and organ donation. | transplantation, patient care, organ donation, organ, training resource | is related to: Kidney Health Initiative | Wikidata: Q4745115, nlx_158377, Crossref funder ID: 100005160, ISNI: 0000 0001 0409 3433, grid.461608.d | https://ror.org/05cqqj259 | SCR_003970 | SciCrunch Registry | 2026-09-26 02:13:39 | 4 | ||||||||
|
Big Ten Cancer Research Consortium Resource Report Resource Website |
Big Ten Cancer Research Consortium (RRID:SCR_004025) | BTCRC | consortium, data or information resource, organization portal, portal | A consortium that aims to transform cancer research through collaborative oncology trials that leverage the scientific and clinical expertise of the Big Ten universities. The goal is to align the conduct of cancer research through collaborative, hypothesis-driven, highly translational oncology trials that leverage the scientific and clinical expertise. The clinical trials that will be developed will be linked to molecular diagnostics, enabling researchers to understand what drives the cancers to grow and what might be done to stop them from growing. The consortium also leverages geographical locations and existing relationships among the cancer centers. One of the consortium's goals is to harmonize contracts and scientific review processes to expedite clinical trials. The consortium will only focus on phase 0 to II trials because larger trials - even a randomized phase II trial - are difficult to conduct at a single cancer center. | oncology, drug development, basic research, clinical trial, clinical, genitourinary, gastrointestinal, thoracic, breast, nanotechnology, virus, triple-negative cell |
is affiliated with: Penn State Milton S. Hershey Medical Center; Pennsylvania; USA is affiliated with: University of Wisconsin-Madison; Wisconsin; USA is affiliated with: Rutgers University; New Jersey; USA is affiliated with: Northwestern University; Illinois; USA is affiliated with: University of Nebraska; Nebraska; USA is affiliated with: University of Minnesota Twin Cities; Minnesota; USA is affiliated with: Michigan State University; Michigan; USA is affiliated with: University of Michigan; Ann Arbor; USA is affiliated with: University of Iowa; Iowa; USA is affiliated with: Indiana University; Indiana; USA is affiliated with: University of Illinois College of Medicine; Illinois; USA has parent organization: Hoosier Cancer Research Network |
Cancer | Public | nlx_158452 | SCR_004025 | SciCrunch Registry | Big Ten CRC | 2026-09-26 02:13:37 | 0 | ||||||
|
Asclepia MedChem Solutions Resource Report Resource Website |
Asclepia MedChem Solutions (RRID:SCR_004023) | commercial organization | Commercial organization that offers medicinal chemistry services and consulting consisting of the combination of structure based drug design and computational chemistry with multi-disciplinary expertise. A proven track record exists in the identification and the delivery of successful drug candidates. They offer solutions within small molecule drug discovery and outsourcing project management. | drug discovery, computation, chemistry, drug, medicine, drug design, small molecule, project managment | is related to: European Gram Negative AntiBacterial Engine | nlx_158536 | SCR_004023 | SciCrunch Registry | Asclepia Outsourcing Solutions BVBA, Asclepia Outsourcing Solutions | 2026-09-26 02:13:37 | 0 | |||||||||
|
Ontology of Physics for Biology Resource Report Resource Website |
Ontology of Physics for Biology (RRID:SCR_004144) | OPB | controlled vocabulary, data or information resource, ontology | A reference ontology of classical physics as applied to the dynamics of biological systems. It is designed to encompass the multiple structural scales (multiscale atoms to organisms) and multiple physical domains (multidomain fluid dynamics, chemical kinetics, particle diffusion, etc.) that are encountered in the study and analysis of biological organisms. | owl | is listed by: BioPortal | nlx_157536 | SCR_004144 | SciCrunch Registry | 2026-09-26 02:13:39 | 0 | |||||||||
|
EU-ADR Resource Report Resource Website 1+ mentions |
EU-ADR (RRID:SCR_004028) | EU-ADR | consortium, data or information resource, organization portal, portal | Consortium that created the capability to detect Adverse Drug Response (ADR) signals by creating the infrastructure for large-scale monitoring of drug safety using electronic health records (EHR). The platform leverages EHR''''s comprising demographics, drug use and clinical data of over 30 million patients from several European countries. Special attention was given to patient groups that are not routinely involved in clinical trials, for ethical or practical reasons (e.g. pregnant women, elderly people, people using many drugs simultaneously, and children). This project also studies and compares a number of different techniques that all aim to detect unexpected or disproportional rates of events. The algorithms that they studied originate not only from the field of (pharmaco)epidemiology, but also from fields such as bio-terrorism, machine learning, and classical signal detection. EU-ADR specific objectives are: To detect events, To relate these events to drugs, To develop hypothesis that explain adverse events, To detect adverse events earlier, and To avoid false positives. The web-based platform is available at https://bioinformatics.ua.pt/euadr/ EU-ADR has contributed to the ability to conduct better drug safety studies based on the re-use of healthcare data. By facilitating the early detection of adverse drug reactions, but also providing key information on populations at risk, potential drug interactions, potential underlying mechanisms and intervening pathways in adverse events, etc., the project will allow for improved and more complete information to be available for drug and healthcare delivery, leading to increased patient safety and its associated cost savings. The EU-ADR system can be considered as a complementary tool to already existing pharamcovigilance systems. Should the system be widespread in the long term, it has the potential to contribute to the development of future electronic health record systems, insofar as the expected benefits of these IT tools are only fully attainable when EHRs develop themselves in consistency, richness and formats that allow them to be subject of such tools. In anticipation, EU-ADR has been designed to be modular and scalable, so that different EHR databases (other than those participating in the Consortium) can be progressively enlisted in the future, adopt the software for data extraction and therefore become susceptible of exploitation by the system, for maximum global effect. | adverse drug reaction, clinical, biomedical, drug safety, electronic health record, demographic, drug use, clinical data, late adult human, child, young human, pregnant, drug, adverse event, signal detection, drug development, data sharing, text mining, epidemiology, database, data set, data repository, text extraction software |
is listed by: Consortia-pedia is related to: Mar Institute of Medical Research Foundation is related to: University of Aveiro; Aveiro; Portugal has parent organization: Mar Institute of Medical Research Foundation has parent organization: University of Aveiro; Aveiro; Portugal |
European Union FP7 | nlx_158456 | SCR_004028 | SciCrunch Registry | Exploring and Understanding Adverse Drug Reactions by Integrative Mining of Clinical Records and Biomedical Knowledge | 2026-09-26 02:13:37 | 9 | |||||||
|
Kyushu University; Fukuoka; Japan Resource Report Resource Website 1+ mentions |
Kyushu University; Fukuoka; Japan (RRID:SCR_004149) | university | Japanese national university located in Fukuoka, in the island of Kyushu. |
is parent organization of: Signaling Pathway Database is parent organization of: Kyushu University Definitive Haplotype Database is parent organization of: ChIP-Atlas |
nlx_23378, Wikidata:Q1188786, ISNI:0000 0001 2242 4849, grid.177174.3, Crossref funder ID:501100004096 | https://ror.org/00p4k0j84 | SCR_004149 | SciCrunch Registry | 2026-09-26 02:13:40 | 1 | ||||||||||
|
Arbor Research Collaborative for Health Resource Report Resource Website 1+ mentions |
Arbor Research Collaborative for Health (RRID:SCR_003972) | Arbor Research | nonprofit organization | A not-for-profit research organization committed to improve patient care through research that shapes medical policies and practice. In particular, they conduct health outcomes research on chronic disease and end-stage organ failure, with expertise in biostatistical analysis, clinical practice, health economics, public policy, database management and integration, and project coordination. Through research projects that are national and global in scope, their scientific collaborations provide valuable and timely information to the worldwide health care community. They are a leader in interdisciplinary health outcomes and policy research focused on reducing the health and economic burden of chronic diseases and improving the delivery of care. | health outcome, patient care, clinical, policy, nephrology, statistics, kidney, transplant, dialysis, epidemiology, public health, clinical practice, policy development, medical payment system | is related to: Kidney Health Initiative | Kidney disease, Organ failure, Chronic disease | grid.413857.c, nlx_158379, ISNI: 0000 0004 0628 9837 | https://ror.org/043qmbk61 | SCR_003972 | SciCrunch Registry | URREA, University Renal Research and Education Association | 2026-09-26 02:13:36 | 3 | ||||||
|
Hoosier Cancer Research Network Resource Report Resource Website |
Hoosier Cancer Research Network (RRID:SCR_004026) | HCRN | nonprofit organization | An independent nonprofit cancer research organization that provides full-service clinical trial management and support, from conception and study design through project completion and publication. Established to explore and develop leading edge cancer treatments across the United States and internationally, their clinical trials, developed in collaboration with academic and community oncologists, are conducted within a member network of more than 130 clinical research sites. Their vision and mission is to form unparalleled relationships between academic, community, pharmaceutical, and biotech partners with the goal of advancing cancer research, education, and patient advocacy. There are no costs to become a member. | oncology, clinical trial, clinical | is parent organization of: Big Ten Cancer Research Consortium | Cancer | nlx_158453, Wikidata: Q30287333, grid.428706.f | https://ror.org/02mtpb511 | SCR_004026 | SciCrunch Registry | Hoosier Oncology Group | 2026-09-26 02:13:37 | 0 | ||||||
|
DanStem Resource Report Resource Website 1+ mentions |
DanStem (RRID:SCR_004021) | DanStem | data or information resource, portal, topical portal | Center consisting of 9 research groups who all address basic questions in stem cell and developmental biology with the overall aim of developing new stem cell-based therapeutic approaches for diabetes and cancer. DanStem comprises two sections: * The Novo Nordisk Foundation Section for Basic Stem Cell Biology (BasicStem) * The Section for Strategic Translational Stem Cell Research and Therapy (TransStem) DanStem was established as a result of a series of international recruitments coupled with internationally recognized research groups focused on insulin producing beta cells and cancer research already located at the University of Copenhagen. They all have well-established, international collaborations and actively participate in several international scientific consortia. DanStem is also active in training undergraduates, PhD students and postdocs. | stem cell, beta cell development, beta cell, insulin |
is related to: Beta Cell Biology Consortium has parent organization: University of Copenhagen; Copenhagen; Denmark |
Diabetes, Cancer | Novo Nordisk Foundation ; Danish Council for Strategic Research |
nlx_158446 | SCR_004021 | SciCrunch Registry | The Danish Stem Cell Center, Danish Stem Cell Center, DanStem - The Center for Stem Cell Research, Danish Center for Stem Cell Research | 2026-09-26 02:13:37 | 4 | ||||||
|
McEwen Centre for Regenerative Medicine Resource Report Resource Website 1+ mentions |
McEwen Centre for Regenerative Medicine (RRID:SCR_004020) | McEwen Centre | data or information resource, laboratory portal, organization portal, portal | Center aiming to be a catalyst for regenerative medicine by facilitating collaboration, supporting research, and promoting awareness of the field. The center includes 15 scientists at five Toronto hospitals, as well as the University of Toronto, currently working to accelerate the development of more effective treatments for conditions such as heart disease, diabetes, respiratory disease and spinal cord injury. They collaborate with many other research institutions throughout North America, Europe and the Asia / Pacific region. The research is powered by a team of recent doctoral graduates recruited from around the world that are selected through a competitive process. They are a critical tool for supporting the work of McEwen Centre, allowing them to find medical breakthroughs faster. | regenerative medicine, stem cell, postdoctoral program resource | is related to: Beta Cell Biology Consortium | Heart disease, Diabetes, Respiratory disease, Spinal cord injury | philanthropic contributions ; research grants |
nlx_158445 | SCR_004020 | SciCrunch Registry | McEwen Center, McEwen Center for Regenerative Medicine | 2026-09-26 02:13:39 | 1 | ||||||
|
American Nephrology Nurses Association Resource Report Resource Website 1+ mentions |
American Nephrology Nurses Association (RRID:SCR_003966) | ANNA | institution | Non-profit professional association that represents nurses who work in all areas of nephrology including hemodialysis, chronic kidney disease, peritoneal dialysis, acute care, and transplantation. Most members work in freestanding dialysis units, hospital outpatient units, and hospital inpatient units. ANNA develops and updates standards of clinical practice, educates practitioners, stimulates and supports research, disseminates knowledge and new ideas, promotes interdisciplinary communication and cooperation, and monitors and addresses issues encompassing the breadth of practice of nephrology nursing. | clinical, kidney, nephrology, nurse, health care, dialysis, journal, training resource |
is related to: Nephrology Nursing Certification Commission is related to: Kidney Health Initiative |
Kidney disease | grid.469735.a, nlx_158371, ISNI: 0000 0000 9310 7210, Crossref funder ID: 100005526 | https://ror.org/05a8c4g41 | SCR_003966 | SciCrunch Registry | American Nephrology Nurses'' Association | 2026-09-26 02:13:39 | 1 | ||||||
|
American Association of Kidney Patients Resource Report Resource Website 1+ mentions |
American Association of Kidney Patients (RRID:SCR_003965) | AAKP | data or information resource, disease-related portal, patient-support portal, portal, topical portal | Association of kidney patients focused on patient-centered education, advocacy and community. They share educational pieces covering every level of kidney disease, advocate for improved access to high-quality health care through regulatory and legislative reform at the federal level, and make an effort to bring kidney patients together to promote community, conversations and to seek out services that help maximize patients'' everyday lives. | kidney, dialysis | is related to: Kidney Health Initiative | Kidney disease | nlx_158369 | SCR_003965 | SciCrunch Registry | 2026-09-26 02:13:36 | 1 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the dkNET Resources search. From here you can search through a compilation of resources used by dkNET and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that dkNET has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on dkNET then you can log in from here to get additional features in dkNET such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into dkNET you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant U24DK097771.
Email: info_at_ dknet.org
